Department of Clinical Pharmacology, Medical University of Vienna
Vienna, 1090, Austria
NCT Number: NCT00431691
Oxidative stress, which refers to cellular damage caused by reactive oxygen intermediates, has been implicated in many disease processes, especially age-related disorders. Many trials investigating use of antioxidants in protecting different tissues against oxidative stress have been conducted, but the results are ambiguous.
Inflammation is generally associated with enhanced oxidative stress and widespread endothelial dysfunction. In the present study, the infusion of LPS, which is a cell wall component of Gram-negative bacteria and a major mediator in the pathogenesis of septic shock, will be used as a standardized experimental model of systemic inflammatory response in humans. The assessment of outcome parameters will include measurements of ocular blood flow, forearm blood flow and plasma concentration of cytokines. Measurements of ocular hemodynamics provide an unique chance to investigate local blood flow in humans non-invasively. Moreover, the retina is especially susceptible to oxidative stress because of its high consumption of oxygen, its high polyunsaturated fatty acid content, and its exposure to visible light. Evidence from literature clearly supports a role for oxidative stress in pathophysiology of several ocular diseases including diabetic retinopathy and age-related macular degeneration. To investigate the retinal vascular reactivity we will use systemic hyperoxia as a stimulus. The measurement of forearm blood flow will be use to assess endothelial function. The main study objective is to investigate the effect of oral vitamins and minerals supplementation on impaired retinal vascular reactivity after LPS administration.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Phase 4
Vienna, 1090, Austria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
dose: 4 tablets daily for two weeks
vitamin A 7160 IU, vitamin C 113mg, vitamin E 100IU, zinc 17.4mg, copper 0.4mg
Other names: Ocuvite preservision
dose: 2 ng/kg (corresponding to 20 IU/kg), intravenous bolus over 5 minutes on both study days
Other names: US Standard Endotoxin
breathing for 30 minutes, 2 breathing periods on both study days
dose: 0,8 mg sublingual, applied during FMD measurements on both study days
Other names: Nitrolingual Pump Spray
Time frame: in total 8x on 2 study days
Time frame: in total 4x on 2 study days
Time frame: in total 4x on 2 study days
Time frame: on 2 study days
Time frame: on 2 study days
Time frame: on 2 study days
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00814008
Autoimmune Diseases, Diabetes Mellitus
Vienna, Austria
View Trial DetailsNCT00709423
Ocular Physiology, Regional Blood Flow
Vienna, Austria
View Trial DetailsNCT03326908
Retina, Tomography, Optical Coherence
Paris, France
View Trial DetailsNCT04794634
Alzheimer Disease, Basal Ganglia Diseases
Amiens, France
View Trial Details